Mark Rupar

2.8k citations

22 papers · 669 indexed · h-index 11

Impact in

Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Hematology top 10%
- Chronic Myeloid Leukemia Treatments

Papers in ⓘ

Genetics 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Chronic Lymphocytic Leukemia Research 3
Hematology 6
- Multiple Myeloma Research and Treatments 3

Co-authors: Gregory Hollis (13 shared papers)Timothy C. Burn (11 shared papers)William P. Donovan (5 shared papers)Reid Huber (9 shared papers)Timothy B. Johnson (3 shared papers)Richard Wynn (6 shared papers)Mark R. Cunningham (2 shared papers)Thomas Malvar (2 shared papers)
Journals: Cancer Research (3 papers)Applied and Environmental Microbiology (3 papers)Blood (3 papers)SLAS DISCOVERY (1 paper)Gene (1 paper)
Partner nations: United States United Kingdom Germany

In The Last Decade

Mark Rupar

22 papers receiving 636 citations

Peers

Countries citing papers authored by Mark Rupar

Since Specialization

Citations

This map shows the geographic impact of Mark Rupar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Rupar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Rupar more than expected).

Fields of papers citing papers by Mark Rupar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Rupar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Rupar. The network helps show where Mark Rupar may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Rupar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Rupar Line = papers co-authored together Mark Rupar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters Gene ·Reid Huber, Kathleen Murphy, Bowman Miao, John R. Link, Mark R. Cunningham, Mark Rupar, Paul L. Gunyuzlu, Thomas F. Haws, Altaf Kassam, Francoise Powell, Gregory Hollis, Peter R. Young, Ranjan Mukherjee, Timothy C. Burn	2002	172
2	Absence of Post-translational Aspartyl β-Hydroxylation of Epidermal Growth Factor Domains in Mice Leads to Developmental Defects and an Increased Incidence of Intestinal Neoplasia Journal of Biological Chemistry ·Joseph Dinchuk, Richard J. Focht, Jennifer Kelley, Nancy Henderson, Nina Zolotarjova, Richard Wynn, Nicola T. Neff, John Link, Reid Huber, Timothy C. Burn, Mark Rupar, Mark R. Cunningham, Bernard Selling, Jianhong Ma, Andrew Stern, Gregory Hollis, Robert B. Stein, Paul A. Friedman	2002	91
3	The Janus Kinase 2 Inhibitor Fedratinib Inhibits Thiamine Uptake: A Putative Mechanism for the Onset of Wernicke’s Encephalopathy Drug Metabolism and Disposition ·Qiang Zhang, Yan Zhang, Sharon Diamond, Jason Boer, Jennifer J. Harris, Yu Li, Mark Rupar, Elham Behshad, Christine Gardiner, Paul Collier, Phillip Liu, Timothy C. Burn, Richard Wynn, Gregory Hollis, Swamy Yeleswaram	2014	85
4	Characterization of two genes encoding Bacillus thuringiensis insecticidal crystal proteins toxic to Coleoptera species Applied and Environmental Microbiology ·William P. Donovan, Mark Rupar, A C Slaney, Thomas Malvar, M C Gawron-Burke, Timothy B. Johnson	1992	68
5	Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis Blood ·Priya Koppikar, Omar Abdel‐Wahab, Cyrus V. Hedvat, Sachie Marubayashi, Jay Patel, Aviva Goel, Nicole Kucine, Jeffrey R. Gardner, Andrew P. Combs, Kris Vaddi, Patrick J. Haley, Timothy C. Burn, Mark Rupar, Jacqueline Bromberg, Mark Heaney, Elisa de Stanchina, Jordan S. Fridman, Ross L. Levine	2010	54
6	Purification of Her-2 extracellular domain and identification of its cleavage site Protein Expression and Purification ·Chao‐Xing Yuan, Amy L Lasut, Richard Wynn, Nicola T. Neff, Gregory Hollis, Michael L Ramaker, Mark Rupar, Phillip Liu, Ray Meade	2003	39
7	Binary Toxins from Bacillus thuringiensis Active against the Western Corn Rootworm, Diabrotica virgifera virgifera LeConte Applied and Environmental Microbiology ·James A. Baum, Chi-Rei Chu, Mark Rupar, G. Brown, William P. Donovan, J. E. Huesing, Oliver Ilagan, Thomas Malvar, Michael Pleau, Matthew Walters, Ty T. Vaughn	2004	34
8	Two novel strains of Bacillus thuringiensis toxic to coleopterans Applied and Environmental Microbiology ·Mark Rupar, William P. Donovan, R. Gene Groat, A C Slaney, James Mattison, Timothy B. Johnson, J F Charles, V. Cosmao Dumanoir, H. de Barjac	1991	26
9	Discovery of INCA033989, a Monoclonal Antibody That Selectively Antagonizes Mutant Calreticulin Oncogenic Function in Myeloproliferative Neoplasms (MPNs) Blood ·Edimara S. Reis, Rebecca A. Buonpane, Hamza Celik, Caroline Marty, Angela Lei, Fatoumata Jobe, Mark Rupar, Yue Zhang, Darlise DiMatteo, Rahel Awdew, William Vainchenker, Jing Zhou, Ian S. Hitchcock, Isabelle Plo, Horacio Nastri, Patrick A. Mayes	2022	24
10	High-Throughput Determination of Mode of Inhibition in Lead Identification and Optimization SLAS DISCOVERY ·Min Wei, Richard Wynn, Gregory Hollis, Boshan Liao, Alexander R. Margulis, Brian G. Reid, Ronald M. Klabe, Phillip C.C. Liu, Mary Becker-Pasha, Mark Rupar, Timothy C. Burn, Dale E. McCall, Yanlong Li	2007	23
11	Insecticidal Activity of EG 4961, a Novel Strain of Bacillus Thuringiensis Toxic to Larvae and Adults of Southern Corn Rootworm (Coleoptera: Chrysomelidae) and Colorado Potato Beetle (Coleoptera: Chrysomelidae) Journal of Economic Entomology ·Timothy B. Johnson, A C Slaney, William P. Donovan, Mark Rupar	1993	16
12	Characterization of INCB00928, a Potent and Selective ALK2 Inhibitor for the Treatment of Anemia Blood ·Yaoyu Chen, Matthew C. Stubbs, Michelle Pusey, Xiaoming Wen, Robert J. Collins, Kanishk Kapilashrami, Mark Rupar, Pramod Thekkat, Luping Lin, Kevin Bowman, Yan‐ou Yang, Sharon Diamond, Swamy Yeleswaram, Sunkyu Kim, Holly K. Koblish, Yingnan Chen, Susan Wee	2020	9
13	Validation of Standards for Quantitative Assessment of JAK2 c.1849G>T (p.V617F) Allele Burden Analysis in Clinical Samples Genetic Testing and Molecular Biomarkers ·Paul Collier, Keyur P. Patel, Paul Waeltz, Mark Rupar, Rajyalakshmi Luthra, Phillip C.C. Liu, Gregory Hollis, Reid Huber, Srđan Verstovšek, Timothy C. Burn	2013	7
14	Abstract C103: The combination of PI3kδ-selective inhibition and immunomodulation shows efficacy in solid tumor models Molecular Cancer Therapeutics ·Holly K. Koblish, Liang-Chuan Wang, Michael Hansbury, Yue Zhang, Gengjie Yang, Timothy C. Burn, Paul Waeltz, Mark Rupar, Eddy W. Yue, Brent Douty, Thomas Maduskuie, Nikoo Falahatpisheh, Yunlong Li, Andrew P. Combs, Gregory Hollis, Reid Huber, Peggy Scherle	2015	5
15	Abstract 4904: The BET inhibitor INCB054329 enhances the activity of checkpoint modulation in syngeneic tumor models Cancer Research ·Holly K. Koblish, Michael Hansbury, Leslie Hall, Liang-Chuan Wang, Yue Zhang, Maryanne Covington, Timothy C. Burn, Mark Rupar, Christine Gardiner, Thomas Condamine, Kerri Lasky, Matthew C. Stubbs, Eddy W. Yue, Richard Sparks, Thomas Maduskuie, Andrew P. Combs, Gregory Hollis, Reid Huber, Phillip CC Liu, Peggy Scherle	2016	4
16	Phosphorylation State-Dependent High Throughput Screening of the c-Met Kinase PubMed ·Elham Behshad, Ronald M. Klabe, Alexander R. Margulis, Mary Becker-Pasha, Mark Rupar, Paul Collier, Phillip C. Liu, Gregory Hollis, Timothy C. Burn, Richard Wynn	2010	2
17	Abstract 4483: Novel small-molecule antagonists of the PD-1/PD-L1 axis that mediate cell surface PD-L1 dimerization and internalization Cancer Research ·Phillip C.C. Liu, Richard Wynn, Liangxing Wu, Alla Volgina, Nina Zolotarjova, Luping Lin, Pramod Thekkat, Alex Margulis, Ronald M. Klabe, Wenqing Yao, Kai‐Jiong Xiao, Jingwei Li, Xin He, Mark Rupar, Hong Chang, Paul Waeltz, Yanlong Li, Peggy Scherle, Reid Huber, Gregory Hollis	2019	2
18	Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents Journal for ImmunoTherapy of Cancer ·Liang‐Chuan S. Wang, Holly K. Koblish, Michael Hansbury, Yue Zhang, Gengjie Yang, Timothy C. Burn, Paul Waeltz, Mark Rupar, Eddy W. Yue, Brent Douty, Thomas Maduskuie, Nikoo Falahatpisheh, Yunlong Li, Andrew P. Combs, Gregory Hollis, Reid Huber, Peggy Scherle	2015	2
19	Abstract 3780: Activity of the BET inhibitor INCB054329 in models of lymphoma Cancer Research ·Matthew C. Stubbs, Robert J. Collins, Alla Volgina, Mike Liu, Margaret Favata, Mark Rupar, Xiaomng Wen, Richard Sparks, Thomas Maduskuie, Maryanne Covington, Timothy C. Burn, Bruce Ruggeri, Andrew P. Combs, Wenqing Yao, Reid Huber, Gregory Hollis, Peggy Scherle, Phillip CC Liu	2016	2
20	Genetics of microcystless mutants of polysphondylium pallidum Developmental Genetics ·David Francis, Mark Rupar	1983	2

About Mark Rupar

Mark Rupar is a scholar working on Genetics, Hematology, Insect Science, Molecular Biology and Oncology, having authored 22 papers that have together received 669 indexed citations. Recurring topics across this work include Insect Resistance and Genetics (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Entomopathogenic Microorganisms in Pest Control (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Protein Degradation and Inhibitors (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Genetics (132 citations), Hematology (105 citations), Insect Science (111 citations), Oncology (226 citations) and Molecular Biology (367 citations). Mark Rupar has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Gregory Hollis, Timothy C. Burn, William P. Donovan, Reid Huber, Timothy B. Johnson, Richard Wynn, Mark R. Cunningham, Thomas Malvar, Bowman Miao and Peter R. Young. Their work appears in journals such as Cancer Research, Applied and Environmental Microbiology, Blood, SLAS DISCOVERY and Gene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact